Dermatology
Ultraviolet light selection assay can optimize oligonucleotide-based therapy
Published in Gene Therapy Weekly, January 20th, 2005
According to recent research published in the journal Gene Therapy, "various oligonucleotide (ODN)-based approaches have been proposed for their ability to correct mutated genes at the normal chromosomal locations. However, the reported gene correction frequencies of these approaches have varied markedly in different experimental settings, including when different tissues or cell types are targeted."
"In order to find the optimal ODN-based approach for a specific target tissue, an assay system that allows direct comparison of the different methods on that tissue is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-01-20)
More Articles from Gene Therapy Weekly
- Gene Therapy
Nuclear factor-kappaB decoy ameliorates endotoxic shock in mice - Oncology
Highly selective adenoviruses show specificity for melanoma cells - Physiology
Diazoxide affects regulation of transporter genes and proteins in hippocampus - Vectors
Scientists achieve nonviral gene delivery in vitro and track it in real-time - Autism
Multimedia product for children with autism launched - Business & Finance
Bacterio-Therapeutics company closes financing, announces new board member - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
